Atrial fibrillation, or Afib, is the most common type of heart arrhythmia. Afib increases your risk of heart attack and ...

The upcoming clinical trial conferences will host talks on supply chain resilience, AI’s growing role and forging industry ...

Researchers from the National Institutes of Health (NIH) are applying artificial intelligence to the recruitment of ...

A revolutionary breakthrough in cataract treatment is on the horizon, with the emergence of C-KAD, a new eye drop therapy.

Ocugen has announced positive Phase 1 trial results for OCU410, a one-time gene therapy for geographic atrophy secondary to ...

Researchers from the National Institutes of Health (NIH) have developed an artificial intelligence (AI) algorithm to help ...

New data from Barinthus Bio's HBV003 trial has demonstrated durable HBsAG loss in participants with chronic hepatitis B.

Results from a randomized, phase 2 clinical trial show that adding high-dose, intravenous (IV) vitamin C to chemotherapy ...

GeoVax Announces Positive Interim Data Review for Phase 2 Clinical Trial of COVID-19 Vaccine Booster in Patients with Chronic Lymphocytic Leukemia ...

Neurogene (NGNE) announced an update on its ongoing Phase 1/2 open-label clinical trial evaluating NGN-401 gene therapy for the treatment of ...

Sage Therapeutics has been working in the area of steroid-derived compounds that affect CNS receptor signaling.

Lilly has reported comprehensive outcomes from the Phase III trial of tirzepatide for individuals with heart failure with ...